Roberta Salmaso

Padova, 35128, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Journal: Cancers
Published: May 12, 2026

IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer.

IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer.

Journal: Cancers
Published: December 23, 2025

IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer.

IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer.

Journal: Surgery
Published: June 10, 2024

IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesions.

IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesions.

Journal: Scientific reports
Published: February 18, 2024

IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.

IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.

Journal: Cancer
Published: September 06, 2023

IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer.

IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer.

Journal: The British journal of surgery
Published: February 17, 2023

Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study.

Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: October 10, 2022

IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort study.

IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort study.

Journal: International journal of surgery (London, England)
Published: September 06, 2022

Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis.

Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis.

Journal: European journal of cancer (Oxford, England : 1990)
Published: October 14, 2020

Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response.

Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response.

Journal: Oncoimmunology
Published: September 14, 2020

Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease.

Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Published: November 06, 2019

High prevalence of human papillomavirus infection in sinonasal inverted papilloma: a single-institution cohort of patients.

High prevalence of human papillomavirus infection in sinonasal inverted papilloma: a single-institution cohort of patients.

Journal: International forum of allergy & rhinology
Published: October 16, 2019
Showing 1-12 of 21

Last Updated: 09/26/2026